natgillin/translations-raw huggingface dataset:
Very common (these may occur with more than 1 in 10 doses of the vaccine)
Foarte frecvente (Acestea pot apărea la 1 din 10 doze sau mai mult de vaccin):
Very common (these may occur with more than 1 in 10 doses of the vaccine):
Foarte frecvente (Acestea pot apărea la 1 din 10 doze sau mai mult de vaccin):
Very common (≥ 1/10)
Creşterea
Very common (≥ 1/10)
Foarte frecvente (≥10)
Very common (≥ 1/10) Common (≥ 1/100 to < 1/10)
Foarte frecvente (≥ 1/10) Frecvente (≥ 1/100 şi < 1/10)
Very Common (≥ 1/10) Common (≥ 1/100 to < 1/10)
Foarte frecvente (≥1/10) Frecvente (≥1/100 şi <1/10)
Very common (≥ 1/10) Common (≥ 1/100 to < 1/10)
Foarte frecvente ( 1/10) Frecvente ( 1/100 şi < 1/10)
Very common (≥ 1/10) Common (≥ 1/100 to < 1/10)
Frecvente ( 1/100 şi < 1/10)
Very common (≥ 1/10), common (≥ 1/100 to 1/10), uncommon (≥1/1,000 to 1/100), rare (≥1/10,000 to 1/1,000)
Foarte frecvente (≥ 1/10), frecvente (≥1/100 şi <1/10), mai puţin frecvente (≥ 1/1000 şi < 1/100); rare (≥ 1/10000 şi <1/1000).
Very common (≥ 1/10), common (≥ 1/100 to 1/10), uncommon (≥1/1,000 to 1/100), rare (≥1/10,000 to 1/1,000)
Foarte frecvente (≥ 1/10), frecvente (≥1/100 şi <1/10), mai puţin frecvente (≥ 1/1000 şi < 1/100); rare (≥ 1/10000 şi <1/1000.
Very common (≥ 1/10); Common (≥ 1/100 to < 1/10);
Foarte frecvente (≥ 1/10); Frecvente (≥ 1/100 şi < 1/10);
Very common (≥ 1/10); Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100 Rare (≥1/10,000 to <1/1,000); Very rare (<1/10,000).
foarte frecvente (≥ 1/10); frecvente (≥ 1/100 şi < 1/10); mai puţin frecvente (≥ 1/1000 şi < 1/100); rare (≥1/10000 şi <1/1000); foarte rare (<1/10000).
Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data).
Foarte frecvente (≥1/10); frecvente (≥1/100 şi <1/10); mai puţin frecvente (≥1/1000 şi <1/100); rare (≥1/10000 şi <1/1000); foarte rare (<1/10000); cu frecvenţă necunoscută (care nu poate fi estimată din datele disponibile).
Very common (≥ 1/10); Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare (≥ 1/10,000 to < 1/1,000); Very rare (< 1/10,000).
foarte frecvente (≥ 1/10); frecvente (≥ 1/100 şi < 1/10); mai puţin frecvente (≥ 1/1000 şi < 1/100); rare (≥1/10000 şi <1/1000); foarte rare (<1/10000).
Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare(< 1/10,000), not known (cannot be estimated from the available data).
Foarte frecvente (≥ 1/10); frecvente (≥ 1/100 şi < 1/10); mai puţin frecvente (≥ 1/1000 şi < 1/100); rare (≥ 1/10000 şi < 1/1000); foarte rare (< 1/10000); cu frecvenţă necunoscută (care nu poate fi estimată din datele disponibile).
Very common (≥ 1/10); Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare (≥1/10,000 to <1/1,000); Very rare (<1/10,000).
foarte frecvente (≥ 1/10); frecvente (≥ 1/100 şi < 1/10); mai puţin frecvente (≥ 1/1000 şi < 1/100); rare (≥1/10000 şi <1/1000); foarte rare (<1/10000).
Very common (≥ 1/10); Common (≥ 1/100 to < 1/10); Uncommon (≥ 1/1,000 to < 1/100); Rare (≥1/10,000 to <1/1,000); Very rare (<1/10,000);.
foarte frecvente (≥ 1/10); frecvente (≥ 1/100 şi < 1/10); mai puţin frecvente (≥ 1/1000 şi < 1/100); rare (≥1/10000 şi <1/1000); foarte rare (<1/10000).
Very common (≥ 1/10); Common (≥ 1/100, < 1/10); Uncommon (≥ 1/1,000, < 1/100)
Foarte frecvente (> 1/10); Frecvente (> 1/100 şi < 1/10); Mai puţin frecvente (> 1/1000 şi < 1/100)
Very common (≥ 1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000).
Foarte frecvente (≥ 1/10); frecvente (≥1/100 şi <1/10); mai puţin frecvente (≥1/1000 şi <1/100); rare (≥1/10000 şi <1/1000); foarte rare (<1/10000).
Very common (≥1/10 patient-years); Common (≥1/100 to <1/10 patient-years);
Frecvente (≥1/100 şi <1/10 pacient-ani);
Very common (≥1/10)
Foarte frecvente (> 1/10)
Very common (≥1/10)
Foarte frecvente (≥ 1/10)
Very common (≥1/10)
toracice
Very common (≥1/10) Common (≥1/100 and <1/10)
Foarte frecvente (≥1/10) Frecvente (≥1/100 și <1/10)
Very common (≥1/10) Common (≥1/100 to <1/10)
Foarte frecvente (≥ 1/10) Frecvente (> 1/100 şi < 1/10)
Very common (≥1/10) Common (≥1/100 to <1/10)
Foarte frecvente (≥1/10) Frecvente (≥1/100 şi <1/10)
Very common (≥1/10) Common (≥1/100 to <1/10)
Foarte frecvente (≥1/10) Frecvente (≥1/100 și <1/10)
Very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare ( 1/10,000 to < 1/1,000)
Foarte frecvente (≥1/10), frecvente (≥1/100 şi <1/10), mai puţin frecvente (≥1/100 şi <1/100), rare (≥1/10000 şi <1/1000) .
Very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare ( 1/10,000 to < 1/1,000)
Foarte frecvente (≥1/10), frecvente (≥1/100 şi <1/10), mai puţin frecvente (≥1/100 şi <1/100), rare (≥1/10000 şi <1/1000).
Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000) and not known (cannot be estimated from the available data).
Foarte frecvente (≥1/10); frecvente (≥1/100 şi <1/10); mai puţin frecvente (≥1/1000 şi <1/100); rare (≥1/10000 şi <1/1000); foarte rare (<1/10000) şi cu frecvenţă necunoscută (care nu se pot estima pe baza datelor disponibile).
Very common ( 1/10 patients): injection site reactions (including pain, swelling, redness or itching).
Foarte frecvente (≥ 1/10 pacienţi): reacţii la locul admnistrării (inclusiv durere, inflamaţie, roşeaţă sau mâncărimi la locul injecţiei).
Very common ( 1/10)
Foarte frecvente (≥ 1/10)
Very common ( 1/10)
foarte frecvente (≥1/10);
Very common ( 1/10)
Foarte frecvente ( 1/10)
Very common ( 1/10) 1
Foarte frecvente (≥1/10)1
Very common ( 1/10) Common ( 1/100 to < 1/10)
Frecvente (1/100 şi <1/10)
Very common ( 1/10); common ( 1/100 to < 1/10); uncommon ( 1/1,000 to < 1/100); rare ( 1/10,000 to < 1/1,000)
Foarte frecvente ( 1/10); frecvente ( 1/100 şi < 1/10); mai puţin frecvente ( 1/1000 şi < 1/100); rare ( 1/10000 şi < 1/1000).
Very common (1/10)
Foarte frecvente (≥ 1/10)
Very common (1/10)
Foarte frecvente (≥1/10)
Very Common (1/10)
Foarte frecvente (1/10)
Very Common (1/10)
Mai puţin frecvente (1/1000, <1/100)
Very common (1/10) Common (1/100 to <1/10)
Foarte frecvente (≥1/10) Frecvente (≥1/100 şi <1/10)
Very common (1/10) Common (1/100 to <1/10)
Foarte frecvente (1/10) Frecvente (1/100 şi <1/10)
Very common (1/10); common (1/100 to <1/10); uncommon (1/1,000 to <1/100); rare (1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data).
Foarte frecvente (≥1/10); frecvente (≥1/100 şi <1/10); mai puţin frecvente (≥1/1000 şi <1/100); rare (≥1/10000 şi <1/1000); foarte rare (<1/10000); cu frecvenţă necunoscută (care nu poate fi estimată din datele disponibile).
Very Common (� 1/10)
Foarte frecvente (≥ 1/10)
Very common - Hypoglycaemia
Foarte frecvente - Hipoglicemie
Very common - Hypoglycaemia
Foarte frecvente – Hipoglicemie
Very common : if you suffer from high blood pressure and type 2 diabetes with kidney disease, blood tests may show an increased level of potassium.
Foarte frecvente: dacă aveţi tensiune arterială crescută şi diabet zaharat de tip 2 cu boală de rinichi, analizele de sânge pot arăta o concentraţie crescută de potasiu.
Very common : Nausea
Foarte frecvente: Greaţă
Very common : vomiting, nausea, diarrhoea, loss of appetite, fever and sensation of sleep
Foarte frecvente: vărsături, greaţă, diaree, pierderea poftei de mâncare, febră şi somnolenţă.
Very common Abdominal pain, Diarrhoea, Nausea
Foarte frecvente Durere abdominală, diaree, greață
Very common Abnormal dreams, insomnia
Foarte frecvente Vise anormale, insomnie
Very common ADRs from the BR 21 and PA 3 studies are presented in Tables 1 and 3, other ADRs including those from other studies are summarized in Table 4.
Reacţiile adverse foarte frecvente raportate în studiile BR 21 şi PA 3 sunt prezentate în Tabelele 1 şi 3, alte reacţii adverse incluzând reacţiile adverse raportate în alte studii sunt prezentate în Tabelul 4:
Very common ADRs in GIOTRIF-treated patients occurring in at least 10% of patients in trial LUX-Lung 3 are summarised by National Cancer Institute-Common Toxicity Criteria (NCI-CTC) Grade in Table 3.
RA foarte frecvente la pacienţii trataţi cu GIOTRIF, raportate la cel puţin 10% dintre pacienţi în studiul LUX-Lung 3, sunt clasificate conform Gradelor de Severitate ale Criteriilor Standard de Toxicitate ale Institutului Naţional al Neoplasmului (NCI-CTC) în Tabelul 3.
Very common ADRs in GIOTRIF-treated patients occurring in at least 10% of patients in trial LUX-Lung 8 are summarised by National Cancer Institute-Common Toxicity Criteria (NCI-CTC) Grade in Table 4.
RA foarte frecvente la pacienţii trataţi cu GIOTRIF, raportate la cel puţin 10% dintre pacienţi în studiul LUX-Lung 8, sunt clasificate conform Gradelor de Severitate ale Criteriilor Standard de Toxicitate ale Institutului Naţional al Neoplasmului (NCI-CTC) în Tabelul 4.
Very common adverse
Reacţii adverse foarte frecvente
Very common adverse events: decreased appetite (including anorexia); lethargy (including calmness and increased sleeping)
Reacţii adverse foarte frecvente: scăderea apetitului (inclusiv anorexie); letargie (inclusiv torpoare şi tendinţă crescută la somn).
Very common adverse reactions
Reacţi adverse foarte frecvente
Very common adverse reactions
Reacţii adverse foarte
Very common adverse reactions
Reacţii adverse foarte frcvente
Very common adverse reactions observed during the three most relevant clinical trials with cladribine in 279 patients treated for various indications and in 62 patients with hairy cell leukaemia (HCL) were myelosuppression, especially severe neutropenia (41% (113/279), HCL 98% (61/62)), severe thrombocytopenia (21% (58/279), HCL 50% (31/62)) and severe anaemia (14% (21/150), HCL 55% (34/62)), as well as severe immunosuppression/lymphopenia (63% (176/279), HCL 95% (59/62)), infections (39% (110/279), HCL 58% (36/62)) and fever (up to 64%).
Reacţiile adverse foarte frecvente observate în cadrul celor trei cele mai relevante studii clinice cu cladribină, efectuate la 279 de pacienţi trataţi pentru diverse indicaţii şi 62 de pacienţi cu leucemie cu celule păroase (HCL), au fost supresia medulară, în special neutropenia severă (41% (113/279), HCL 98% (61/62)), trombocitopenia severă (21% (58/279), HCL 50% (31/62)) şi anemia severă (14% (21/150), HCL 55% (34/62)), precum şi imunosupresia/limfopenia severă (63% (176/279), HCL 95% (59/62)), infecţii (39% (110/279), HCL 58% (36/62)) şi febră (până la 64%).
Very common adverse reactions:
Reacţii adverse foarte frecvente:
Very common adverse reactions: decreased appetite (including anorexia); lethargy.
Reacţii adverse foarte frecvente: scăderea apetitului (inclusiv anorexie); letargie.
very common affects more than 1 user in 10
foarte frecvente afectează mai mult de 1 utilizator din 10
Very common Anaemia
Foarte frecvente Anemie
Very common anterior chamber inflammation, eye pain, increased intraocular pressure, punctate keratitis, vitreous floaters and vitreous opacities
Foarte frecvente Inflamare a camerei anterioare, durere oculară, creştere a presiunii intraoculare, keratită punctiformă, flocoane şi opacităţi vitroase;
Very common Common
Frecvente
Very common Common
Mai puţin frecvente hematurie
Very common Common Common Common
Foarte frecvente
Very common Common Common Common
Foarte frecvente Frecvente Frecvente
Very common Common Common Common Uncommon Rare
Mai puţin frecvente
Very Common Common Uncommon Not known
Bronşită Bronşiolită
Very Common Common Uncommon Not known
Foarte frecvente Frecvente Mai puţin frecvente
Very common Cough
Foarte frecvente Tuse
Very Common Decreased appetite Common
Foarte frecvente Inapetență Frecvente
Very Common Depression, Insomnia Uncommon
Foarte frecvente Depresie, insomnie
Very common Diarrhoea, flatulence, abdominal pain
Foarte frecvente: Frecvente: diaree, flatulenţă, dureri abdominale
Very Common Dizziness, Headache Common Paraesthesia
Foarte frecvente Amețeală, cefalee Frecvente Parestezie
Very Common Dizziness, somnolence, headache
Foarte frecvente Ameţeală, somnolenţă, cefalee
Very Common Dyspnoea, Epistaxis^
Foarte frecvente Dispnee, epistaxis^
Very Common Dyspnoeia
Foarte frecvente Dispnee
Very common Ecchymosis
Foarte frecvente Echimoze
Very common effects – may affect more than 1 in 10 people
Reacţii foarte frecvente – pot afecta mai mult de 1 persoană din 10
Very Common Epistaxis^
Foarte frecvente Epistaxis^
Very common events (reported in ≥ 10% of Perjeta monotherapy-treated patients) are marked in the Table with a †.
Reacţiile foarte frecvente (raportate la ≥ 10% dintre pacienţii trataţi cu Perjeta în monoterapie) sunt marcate în tabel cu †.
Very Common Fatigue Pyrexia
Foarte frecvente Fatigabilitate Pirexie
Very common Fatigue, Febrile neutropenia, Pyrexia Common Asthenia, Oedema peripheral, Chills, Malaise Investigations
Foarte frecvente Fatigabilitate, neutropenie febrilă, febră Frecvente Astenie, edem periferic, frisoane, stare de rău Investigații diagnostice
Very common feeling generally weak and tired.
Foarte frecvente stare generală de slăbiciune şi oboseală.
Very common Headache
Foarte frecvente Cefalee
Very Common Headache Common
Foarte frecvente Cefalee Frecvente
Very common Headache, Dizziness
Foarte frecvente Cefalee, amețeli
Very Common Hypothyroidism
Foarte frecvente Hipotiroidism
Very common in adults, common in children: Peripheral oedema, oedema Common: Asthenia, injection site reaction
Foarte frecvente la adulţi, frecvente la copii: edem periferic, edem Frecvente: astenie, reacţii la nivelul locului de injectare
Very common may affect more than 1 in 10 people
Foarte frecvente: care pot afecta mai mult de 1 din 10 persoane
Very common may affect more than 1 in 10 people
Foarte frecvente: pot afecta mai mult de 1 din 10 persoane
Very common Myalgia
Foarte frecvente Mialgie
Very common Nasopharyngitis♦, upper respiratory tract infection♦
Foarte frecvente Rinofaringită♦, infecție a căilor respiratorii superioare♦
Very common Nausea
Foarte frecvente Greaţă
Very common Nausea, Diarrhoea
Foarte frecvente Greaţă, diaree,
Very Common Neutropenia Leukopenia Anaemia Lymphopenia Thrombocytopenia
Foarte frecvente Neutropenie Leucopenie Anemie Limfopenie Trombocitopenie
Very Common Neutropenia Thrombocytopenia Anaemia
Foarte frecvente Neutropenie Trombocitopenie Anemie
Very Common Neutropenia Thrombocytopenia Leucopenia Anaemia
Foarte frecvente Neutropenie Trombocitopenie Leucopenie Anemie
Very Common Neutropenia^,
Foarte frecvente
Very Common Peripheral neuropathy* Tremor
Foarte frecvente Neuropatie periferică* Tremor
Very Common Peripheral oedema Common
Foarte frecvente Edem periferic Frecvente Pirexie
Very Common Pneumonia◊ Common
Foarte recvente Pneumonie◊ Frecvente
Very common Pruritus, Alopecia
Foarte frecvente Prurit, alopecie
Very common rash (12.5 %)
Foarte frecvente erupţii cutanate tranzitorii (12,5%)
Very Common Rashes, Pruritus Common
Foarte frecvente Erupții cutanate, prurit Frecvente
Very common reactions (may affect more than 1 in 10 people)
Reacţii foarte frecvente ( pot să afecteaze mai mult de 1 din 10 persoane vaccinate)
Very common reactions reported in 146 infants and toddlers 6 to 35 months of age:
Reacţiile foarte frecvente raportate la 146 de sugari şi copii mici cu vârsta cuprinsă între 6 şi 35 de luni:
Very common reversible oligo- and azo-spermia have been observed in man, although these disorders are also associated with the underlying disease.
Cazuri foarte frecvente oligospermie sau azoospermie reversibile au fost observate la oamenideşi aceste tulburări sunt, de asemenea, asociate bolii preexistente.
Very common serious side effects (may affect more than 1 in 10 people):
Reacţiile adverse grave foarte frecvente (pot afecta mai mult de 1 din 10 persoane):
Very common side effect that may show up in your blood or urine tests:
Reacţii adverse foarte frecvente care pot apărea la testele de sânge sau de urină:
Very common side effect: itching around the site of patch application
Reacţii adverse foarte frecvente: mâncărimi în jurul locului de aplicare a plasturelui
Very common side effects
Reacţii adverse raportate foarte frecvent:
Very common side effects
Reacţiile adverse foarte frecvente
Very common side effects (affects 1 or more users in 10)
Reacţii adverse foarte frecvente (afectează 1 sau mai mulți utilizatori din 10)
Very common side effects (affects more than 1 in 10 people):
Reacţii adverse foarte frecvente (afectează mai mult de 1 din 10 persoane):
Very common side effects (affects more than 1 patient in 10)
Reacţii adverse foarte frecvente (afectează mai mult de 1 pacient din 10)
Very common side effects (affects more than 1 patient in 10)
Reacții adverse foarte frecvente (afectează mai mult de 1 pacient din 10)
VERY COMMON side effects (affects more than 1 user in 10):
Reacţii adverse FOARTE FRECVENTE (afectează mai mult de 1 utilizator din 10 ):
VERY COMMON side effects (affects more than 1 user in 10):
Reacţii adverse FOARTE FRECVENTE (afectează mai mult de 1 utilizator din 10):
Very common side effects (at least 1 in 10 people are affected)
Reacţii adverse foarte frecvente (cel puţin 1 din 10 persoane este afectată)
Very common side effects (likely to affect more than 1 in 10 patients): headache
Reacţii adverse foarte frecvente (cu probabilitate de a afecta mai mult de 1 din 10 pacienţi): cefalee
Very common side effects (may affect more than 1 in 10 infusions):
Reacţii adverse foarte frecvente (pot apărea la mai mult de 1 din 10 perfuzii):
Very common side effects (may affect more than 1 in 10 patients):
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 pacienţi):
Very common side effects (may affect more than 1 in 10 patients): bleeding on the surface of the eye
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 pacient din 10): sângerare pe suprafaţa ochiului
Very common side effects (may affect more than 1 in 10 people )
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane)
Very common side effects (may affect more than 1 in 10 people who take Filgrastim HEXAL)
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane care iau Filgrastim HEXAL)
Very common side effects (may affect more than 1 in 10 people who take Zarzio)
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane care iau Zarzio)
Very common side effects (may affect more than 1 in 10 people)
Foarte frecvente (pot afecta mai mult de 1 din 10 persoane)
Very common side effects (may affect more than 1 in 10 people)
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 pacient din 10)
Very common side effects (may affect more than 1 in 10 people)
Reacţii adverse raportate foarte frecvent (pot apărea la mai mult de 1 din 10 persoane)
Very common side effects (may affect more than 1 in 10 people) are:
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane) sunt:
Very common side effects (may affect more than 1 in 10 people) cold-like symptoms.
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane) simptome asemănătoare gripei.
Very common side effects (may affect more than 1 in 10 people) diarrhoea, nausea (feeling sick), injection site redness or irritation
Reacţii adverse foarte frecvente (pot apărea la mai mult de 1 din 10 persoane) diaree, greaţă (senzaţie de rău), înroşire sau iritaţie la nivelul locului injecţiei
Very common side effects (may affect more than 1 in 10 people) diarrhoea, usually mild and temporary.
Reacţii adverse foarte frecvente (pot apărea la mai mult de 1 din 10 persoane) diaree, de obicei uşoară şi trecătoare
Very common side effects (may affect more than 1 in 10 people) diarrhoea.
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 utilizator din 10) diaree
Very common side effects (may affect more than 1 in 10 people) fever (in children)
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane) febră (la copii)
Very common side effects (may affect more than 1 in 10 people) include weight gain; sleepiness and increases in levels of prolactin in the blood.
Reacţii adverse foarte frecvente (care pot afecta mai mult de 1 din 10 persoane) includ creştere în greutate, somnolenţă şi creşteri ale valorilor prolactinei din sânge.
Very common side effects (may affect more than 1 in 10 people) include weight gain; sleepiness and increases in levels of prolactin in the blood.
Reacţii adverse foarte frecvente (care pot afecta mai mult de 1 din 10 persoane) includ creştere în greutate; somnolenţă şi creşterea concentraţiilor în sânge a hormonului prolactină.
Very common side effects (may affect more than 1 in 10 people) include weight gain; sleepiness and increases in levels of prolactin in the blood.
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane) incluzând creştere în greutate, somnolenţă şi creştere a valorilor prolactinei din sânge.
Very common side effects (may affect more than 1 in 10 people) include weight gain; sleepiness; and increases in levels of prolactin in the blood.
Reacţii adverse foarte frecvente(pot afecta mai mult de 1 din 10 persoane) incluzând creştere în greutate, somnolenţă şi creştere a valorilor prolactinei din sânge.
Very common side effects (may affect more than 1 in 10 people) include weight gain; sleepiness; and increases in levels of prolactin in the blood. .
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane) incluzând creştere în greutate, somnolenţă şi creştere a valorilor prolactinei din sânge.
Very common side effects (may affect more than 1 in 10 people) include:
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane) incluzând
Very common side effects (may affect more than 1 in 10 people) inhibitor development for patients who have never been previously treated with factor VIII products
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 persoană din 10) apariţia inhibitorului la pacienţi care nu au fost niciodată trataţi anterior cu medicamente care conţin factor VIII
Very common side effects (may affect more than 1 in 10 people) of RILUTEK are:
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane) la RILUTEK sunt:
Very common side effects (may affect more than 1 in 10 people) of Riluzole Zentiva are:
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane) la Riluzole Zentiva sunt:
Very common side effects (may affect more than 1 in 10 people) redness, swelling and sores on the palms of your hands and feet.
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane): roşeaţă, umflături şi dureri la nivelul palmelor şi tălpilor.
Very common side effects (may affect more than 1 in 10 people) skin rash.
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane) erupţie pe piele.
Very common side effects (may affect more than 1 in 10 people):
Reacţii adverse foarte frecvente ( pot afecta mai mult de 1 din 10 pacienţi):
Very common side effects (may affect more than 1 in 10 people):
Reacţii adverse foarte frecvente (care apar la mai mult de 1 din 10 persoane):
Very common side effects (may affect more than 1 in 10 people):
Reacţii adverse foarte frecvente (care pot afecta mai mult de 1 din 10 persoane):
Very common side effects (may affect more than 1 in 10 people):
Reacţii adverse foarte frecvente (pot afecta până la 1 din 10 persoane):
Very common side effects (may affect more than 1 in 10 people):
Reacţii adverse foarte frecvente (pot apărea la mai mult de 1 din 10 persoane):
Very common side effects (may affect more than 1 in 10 people):
Reacţii adverse foarte frecvente (pot să afecteze mai mult de 1 din 10 persoane):
Very common side effects (may affect more than 1 in 10 people):
Reacţiile adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane):
Very common side effects (may affect more than 1 in 10 people):
Reacții adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane)
Very common side effects (may affect more than 1 in 10 people): bone pain.
Reacţii adverse foarte frecvente (pot afecta mai mult de 1 din 10 persoane): durerea osoasă.